Status:

TERMINATED

The RECOVER sUb-study, Which Leverages quaNtitative and Credible Research tOols From Verily, Will providE Assessment measuRes for Depressive Episodes

Lead Sponsor:

LivaNova

Conditions:

Treatment Resistant Depression

Eligibility:

All Genders

18+ years

Brief Summary

The objective of this study is to collect both active and passive data using a wearable, multi-sensor device (Verily Study Watch) and phone application (Mood App) which aims to capture mental health s...

Detailed Description

A prospective, observational, exploratory study collecting passive and active behavioral, environmental and physiological data, via the use of an Android smartphone application and Study Watch. This ...

Eligibility Criteria

Inclusion

  • All Subjects
  • Current consented subject in the RECOVER clinical trial;
  • Adult (i.e. ≥ 18 years of age, unless a resident of any U.S. state where the age of majority is 19, in which case must be ≥ 19 years of age);
  • Able and willing to provide written informed consent for this sub-study;
  • Able and willing to comply with all study procedures;
  • Able to read and speak English.
  • Phone Application
  • Have a personal Google user account or be willing to create and own a personal Google user account;
  • Owns a personal Android smartphone with a data plan and is the sole user of that smartphone;
  • Agrees to download and maintain the phone application onto personal Android smartphone for the duration of the sub-study;
  • Study Watch
  • 1\. Willing to comply with Study Watch wearing and recharging requirements

Exclusion

  • All Subjects
  • 1\. Any condition or situation the Principal Investigator determines as inappropriate for study inclusion
  • Phone Application
  • No additional exclusion criteria for phone application
  • Study Watch
  • 1\. Subjects with known severe allergy to nickel or metal jewelry

Key Trial Info

Start Date :

March 23 2021

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

September 6 2024

Estimated Enrollment :

138 Patients enrolled

Trial Details

Trial ID

NCT04753385

Start Date

March 23 2021

End Date

September 6 2024

Last Update

December 20 2024

Active Locations (33)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 9 (33 locations)

1

University of Alabama at Birmingham

Birmingham, Alabama, United States, 35294

2

ATP Clinical Research, Inc.

Costa Mesa, California, United States, 92626

3

Keck Hospital of USC

Los Angeles, California, United States, 90033

4

SF-Care, Inc.

San Rafael, California, United States, 94901

The RECOVER sUb-study, Which Leverages quaNtitative and Credible Research tOols From Verily, Will providE Assessment measuRes for Depressive Episodes | DecenTrialz